샘플 요청 목록

 카트 문의
시장보고서
상품코드
1770157

세계의 G 단백질 연결 수용체(GPCRs) 시장

G-Protein Coupled Receptors (GPCRs)
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 359 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

G 단백질 연결 수용체(GPCRs) 세계 시장은 2030년까지 51억 달러에 달할 전망

2024년에 36억 달러로 추정되는 G 단백질 연결 수용체(GPCRs) 세계 시장은 2024년부터 2030년까지 CAGR 6.2%로 성장하여 2030년에는 51억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 세포 라인은 CAGR 6.1%를 기록하며 분석 기간 종료까지 19억 달러에 달할 것으로 예측됩니다. 검출 키트 분야의 성장률은 분석 기간 동안 CAGR 6.7%로 추정됩니다.

미국 시장은 12억 달러로 추정, 중국은 CAGR 8.8%로 성장 예측

미국의 G 단백질 연결 수용체(GPCRs) 시장은 2024년에 12억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 8.8%로 2030년까지 4억 1,690만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 5.2%와 6.1%로 예측됩니다. 유럽에서는 독일이 CAGR 5.8%로 성장할 것으로 예측됩니다.

세계의 G 단백질 연결 수용체(GPCRs) 시장 - 주요 동향과 촉진요인 정리

G 단백질공액수용체(GPCRs)는 세포 내 신호전달에 중요한 역할을 하는 거대하고 다양한 막단백질 군입니다. 이들 수용체는 호르몬, 신경전달물질, 환경 자극물질 등 다양한 세포외 신호에 반응하여 광범위한 생리적 과정에 관여하며, GPCR은 7개의 막 관통 나선으로 구조적으로 특징지어지며, G 단백질과의 결합 및 활성화를 통해 세포 내 신호전달 경로를 활성화합니다. 활성화합니다. 이러한 활성화는 시각, 미각, 후각, 후각, 면역 반응과 같은 중요한 기능을 조절하는 일련의 다운스트림 작용을 유발하며, GPCR의 다양성과 편재성으로 인해 GPCR은 세포 커뮤니케이션 및 약리학 연구의 초점이 되고 있습니다.

GPCR의 중요성은 치료법 개발에도 영향을 미쳐 현대 의약품의 대부분이 GPCR을 표적으로 삼고 있으며, FDA에서 승인된 의약품의 약 34%가 GPCR을 표적으로 삼고 있어 GPCR의 치료 잠재력을 강조하고 있습니다. 이들 의약품은 심혈관질환, 정신질환, 암을 포함한 다양한 질환의 치료에 사용되고 있습니다. 저온 전자현미경 및 X선 결정 구조 분석과 같은 구조 생물학의 발전으로 GPCR의 구조에 대한 자세한 지식을 얻을 수 있게 되어 보다 선택적이고 효과적인 약물의 설계가 용이해졌습니다. 또한, 동종 조절 및 바이어스 작용과 같은 새로운 접근법은 리간드에 대한 수용체의 반응을 미세 조정하여 효능이 향상되고 부작용이 적은 약물을 개발할 수 있는 기회를 제공하고 있습니다.

GPCR 시장의 성장은 여러 가지 요인에 의해 주도되고 있습니다. 기술의 발전으로 GPCR의 구조와 기능에 대한 이해가 크게 향상되어 보다 타겟이 명확하고 효율적인 의약품 개발 프로세스가 가능해졌습니다. 만성질환의 유병률 증가와 보다 효과적인 치료법의 필요성은 GPCR을 표적으로 하는 새로운 치료법에 대한 수요를 촉진하고 있습니다. 또한, 제약 업계가 개별 질병 상태와 관련된 특정 GPCR을 식별하는 맞춤형 의료에 초점을 맞추면서 맞춤형 치료법 개발에 박차를 가하고 있습니다. 고처리량 스크리닝 기술과 컴퓨터 신약 개발 도구의 확장으로 잠재적인 GPCR 조절제 발굴이 가속화되고 있습니다. GPCR에 대한 이해가 깊어지고 새로운 기술이 등장함에 따라, GPCR 표적 치료제 시장은 다양한 질병 영역에서 GPCR 표적 치료제 시장의 강력한 성장과 함께 다양한 미충족 의료 수요를 충족시킬 수 있을 것으로 기대됩니다. 미충족 의료 수요를 충족시키고 환자의 예후를 개선할 수 있을 것으로 기대됩니다.

부문

제품 유형(세포주, 검출 키트, 세포배양 시약, 리간드), 어세이 유형(cAMP 기능 어세이, 칼슘 기능 어세이, B-아레스틴 기능 어세이, 방사성 리간드 결합·GTPyS 기능 어세이, 내재화 어세이, 기타 어세이 유형), 용도(암 연구, 대사 연구, 염증 연구, 중추신경계 연구, 호흡기계 연구, 순환기계 연구, 기타 용도)

조사 대상 기업 사례

  • Merck KGaA
  • BD Biosciences
  • Enzo Life Sciences, Inc.
  • Lexicon Pharmaceuticals, Inc.
  • Molecular Devices LLC
  • Aragen Life Sciences Pvt. Ltd.
  • Axxam SpA
  • Abcam PLC
  • Eurofins Scientific SE
  • HD Biosciences Co., Ltd.
  • Addex Therapeutics
  • Multispan, Inc.
  • Creative Biolabs
  • Beacon Discovery
  • Distributed Bio

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

ksm

Global G-Protein Coupled Receptors (GPCRs) Market to Reach US$5.1 Billion by 2030

The global market for G-Protein Coupled Receptors (GPCRs) estimated at US$3.6 Billion in the year 2024, is expected to reach US$5.1 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Cell Lines, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$1.9 Billion by the end of the analysis period. Growth in the Detection Kits segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 8.8% CAGR

The G-Protein Coupled Receptors (GPCRs) market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$416.9 Million by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global G-Protein Coupled Receptors (GPCRs) Market - Key Trends & Drivers Summarized

G-Protein Coupled Receptors (GPCRs) are a vast and diverse group of membrane proteins that play crucial roles in cellular signal transduction. These receptors are involved in a wide array of physiological processes by responding to various extracellular signals, including hormones, neurotransmitters, and environmental stimulants. Structurally characterized by their seven transmembrane helices, GPCRs activate intracellular signaling pathways through the binding and activation of G-proteins. This activation triggers a cascade of downstream effects that regulate essential functions such as vision, taste, smell, and immune responses. The versatility and ubiquity of GPCRs make them a focal point in the study of cellular communication and pharmacology.

The significance of GPCRs extends into therapeutic development, as they are prominent targets for a large proportion of modern pharmaceuticals. Approximately 34% of all FDA-approved drugs target GPCRs, underscoring their therapeutic potential. These drugs are used to treat a variety of conditions, including cardiovascular diseases, mental health disorders, and cancers. Advances in structural biology, such as cryo-electron microscopy and X-ray crystallography, have provided detailed insights into GPCR structures, facilitating the design of more selective and effective drugs. Furthermore, novel approaches like allosteric modulation and biased agonism offer opportunities to develop drugs with improved efficacy and fewer side effects by fine-tuning the receptor's response to ligands.

The growth in the GPCR market is driven by several factors. Technological advancements have significantly enhanced our understanding of GPCR structures and functions, leading to more targeted and efficient drug development processes. The increasing prevalence of chronic diseases and the need for more effective treatments drive the demand for new GPCR-targeted therapies. Additionally, the pharmaceutical industry's focus on personalized medicine and the identification of specific GPCRs associated with individual disease states has spurred the development of tailored therapeutic interventions. The expansion of high-throughput screening techniques and computational drug discovery tools has accelerated the identification of potential GPCR modulators. Furthermore, collaborative efforts between academic institutions, biotechnology companies, and pharmaceutical giants have facilitated significant progress in GPCR research and drug development. As the understanding of GPCRs continues to deepen and new technologies emerge, the market for GPCR-targeted therapies is expected to experience robust growth, addressing unmet medical needs and improving patient outcomes across various disease areas.

SCOPE OF STUDY:

The report analyzes the G-Protein Coupled Receptors (GPCRs) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Cell Lines, Detection Kits, Cell Culture Reagents, Ligands); Assay Type (cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays, Other Assay Types); Application (Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 52 Featured) -

  • Merck KGaA
  • BD Biosciences
  • Enzo Life Sciences, Inc.
  • Lexicon Pharmaceuticals, Inc.
  • Molecular Devices LLC
  • Aragen Life Sciences Pvt. Ltd.
  • Axxam SpA
  • Abcam PLC
  • Eurofins Scientific SE
  • HD Biosciences Co., Ltd.
  • Addex Therapeutics
  • Multispan, Inc.
  • Creative Biolabs
  • Beacon Discovery
  • Distributed Bio

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • G-Protein Coupled Receptors (GPCRs) - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • GPCR: An Introduction
    • Important Role of GPCRs in Drug Discovery
    • Popular Types of GPCRs of Therapeutic Interest
    • Classification of GPCRs
    • Orphan GPCRs: A Promising Area for Drug Discovery
    • GPCR Signaling Pathways
    • Physiological Roles Performed by GPCRs
    • Outlook
    • Geographic Market Analysis
    • Challenges
    • Competition
    • Recent Market Activity
    • World Brands
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Therapeutic Potential of GPCRs Gains Wide Recognition
    • Allosteric Modulators and Implication of Allostery in Drug Discovery
    • GPCRs Registered as Targets for Approved Drugs with EMBL-CHEMBL, IUPHAR, and The DrugBank
    • GPCRs Registered as Targets for Approved Drugs with EMBL-CHEMBL
    • GPCRs Registered as Targets for Approved Drugs with International Union of Basic and Clinical Pharmacology (IUPHAR)
    • GPCRs Registered as Targets for Approved Drugs with The DrugBank
    • Hurdles Faced...
    • Developments in Structural Biology and Receptor Pharmacology Offer Novel Opportunities to GPCR Drug Discovery
    • In Silico Approaches Underway for GPCR Drug Screening
    • Microfluidic Cell Technology Holds Potential
    • Pipeline GPCR Drug Candidates Widen Prospects
    • Select GPCR Small Molecule Drugs in Active Clinical Development
    • GPCR Ligands (Agonist) in Phase III Clinical Development
    • GPCR Ligands (Antagonist) in Phase III Clinical Development
    • New Indications to Aid Growth
    • CRISPR Holds Potential to Speed Up GPCR-based Drug Discovery
    • GPCR-targeted Drugs and Role in Cancer Treatment
    • Select FDA Approved Drugs and Antibodies against Various Cancer Types
    • Potential GPCR targets for Cancer Treatment
    • Anti GPCRs Drugs and Antibodies under Clinical Trials
    • Rising Incidence of Cancer to Drive Drives Opportunities
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • GPCRs Evolve as Important targets for developing novel therapeutics for Neurodegerative Disorders
    • Number of Individuals Suffering from Alzheimer's in the US: 2020 and 2025
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • GPCRs: An Important Target for Cardiovascular Drugs
    • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • GPCR Screening and Targeting Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for G-Protein Coupled Receptors (GPCRs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Cell Lines by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Detection Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Detection Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Detection Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cell Culture Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cell Culture Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Cell Culture Reagents by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Ligands by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Ligands by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Ligands by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for cAMP Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for cAMP Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for cAMP Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Calcium Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Calcium Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Calcium Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for B-Arrestin Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for B-Arrestin Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for B-Arrestin Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Radioligand Binding & GTPyS Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Radioligand Binding & GTPyS Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Radioligand Binding & GTPyS Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Internalization Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Internalization Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Internalization Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Assay Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Assay Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Other Assay Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Cancer Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Metabolic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Metabolic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 39: World 15-Year Perspective for Metabolic Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Inflammation Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Inflammation Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 42: World 15-Year Perspective for Inflammation Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 43: World Recent Past, Current & Future Analysis for CNS Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 44: World Historic Review for CNS Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 45: World 15-Year Perspective for CNS Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 46: World Recent Past, Current & Future Analysis for Respiratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 47: World Historic Review for Respiratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 48: World 15-Year Perspective for Respiratory Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 49: World Recent Past, Current & Future Analysis for Cardiovascular Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 50: World Historic Review for Cardiovascular Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 51: World 15-Year Perspective for Cardiovascular Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 52: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 53: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 54: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 55: World G-Protein Coupled Receptors (GPCRs) Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 56: USA Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: USA 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: USA 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 65: Canada Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 68: Canada Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Canada 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Canada 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 74: Japan Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Japan 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 83: China Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 104: France Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 113: Germany Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 122: Italy Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 131: UK Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: UK 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 134: UK Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: UK 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 158: Rest of World Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of World Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of World 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Revenues for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of World Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of World Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of World 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Revenues for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of World Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of World Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of World 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Revenues for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제